Cargando…

Designing Lead Optimisation of MMP-12 Inhibitors

The design of new molecules with desired properties is in general a very difficult problem, involving heavy experimentation with high investment of resources and possible negative impact on the environment. The standard approach consists of iteration among formulation, synthesis, and testing cycles,...

Descripción completa

Detalles Bibliográficos
Autores principales: Borrotti, Matteo, De March, Davide, Slanzi, Debora, Poli, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913506/
https://www.ncbi.nlm.nih.gov/pubmed/24527058
http://dx.doi.org/10.1155/2014/258627
_version_ 1782302236172353536
author Borrotti, Matteo
De March, Davide
Slanzi, Debora
Poli, Irene
author_facet Borrotti, Matteo
De March, Davide
Slanzi, Debora
Poli, Irene
author_sort Borrotti, Matteo
collection PubMed
description The design of new molecules with desired properties is in general a very difficult problem, involving heavy experimentation with high investment of resources and possible negative impact on the environment. The standard approach consists of iteration among formulation, synthesis, and testing cycles, which is a very long and laborious process. In this paper we address the so-called lead optimisation process by developing a new strategy to design experiments and modelling data, namely, the evolutionary model-based design for optimisation (EDO). This approach is developed on a very small set of experimental points, which change in relation to the response of the experimentation according to the principle of evolution and insights gained through statistical models. This new procedure is validated on a data set provided as test environment by Pickett et al. (2011), and the results are analysed and compared to the genetic algorithm optimisation (GAO) as a benchmark. The very good performance of the EDO approach is shown in its capacity to uncover the optimum value using a very limited set of experimental points, avoiding unnecessary experimentation.
format Online
Article
Text
id pubmed-3913506
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-39135062014-02-13 Designing Lead Optimisation of MMP-12 Inhibitors Borrotti, Matteo De March, Davide Slanzi, Debora Poli, Irene Comput Math Methods Med Research Article The design of new molecules with desired properties is in general a very difficult problem, involving heavy experimentation with high investment of resources and possible negative impact on the environment. The standard approach consists of iteration among formulation, synthesis, and testing cycles, which is a very long and laborious process. In this paper we address the so-called lead optimisation process by developing a new strategy to design experiments and modelling data, namely, the evolutionary model-based design for optimisation (EDO). This approach is developed on a very small set of experimental points, which change in relation to the response of the experimentation according to the principle of evolution and insights gained through statistical models. This new procedure is validated on a data set provided as test environment by Pickett et al. (2011), and the results are analysed and compared to the genetic algorithm optimisation (GAO) as a benchmark. The very good performance of the EDO approach is shown in its capacity to uncover the optimum value using a very limited set of experimental points, avoiding unnecessary experimentation. Hindawi Publishing Corporation 2014 2014-01-12 /pmc/articles/PMC3913506/ /pubmed/24527058 http://dx.doi.org/10.1155/2014/258627 Text en Copyright © 2014 Matteo Borrotti et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Borrotti, Matteo
De March, Davide
Slanzi, Debora
Poli, Irene
Designing Lead Optimisation of MMP-12 Inhibitors
title Designing Lead Optimisation of MMP-12 Inhibitors
title_full Designing Lead Optimisation of MMP-12 Inhibitors
title_fullStr Designing Lead Optimisation of MMP-12 Inhibitors
title_full_unstemmed Designing Lead Optimisation of MMP-12 Inhibitors
title_short Designing Lead Optimisation of MMP-12 Inhibitors
title_sort designing lead optimisation of mmp-12 inhibitors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913506/
https://www.ncbi.nlm.nih.gov/pubmed/24527058
http://dx.doi.org/10.1155/2014/258627
work_keys_str_mv AT borrottimatteo designingleadoptimisationofmmp12inhibitors
AT demarchdavide designingleadoptimisationofmmp12inhibitors
AT slanzidebora designingleadoptimisationofmmp12inhibitors
AT poliirene designingleadoptimisationofmmp12inhibitors